This compound is a protected nucleoside derivative featuring a triazole-substituted pyrimidine base and a furodioxolane core, commonly utilized as a pharmaceutical intermediate in nucleoside synthesis. Its structure incorporates an ester-linked isobutyrate group, which serves as a synthetic handle for further functionalization in drug development.
نطاق المحتوى: تتعلق المعلومات الواردة في هذه الصفحة بتحديد المواد الكيميائية وبسياقات التوريد الصناعي والبحث والإنتاج. وهي لا تشكّل ادعاءً علاجياً أو نصيحة طبية أو إرشادات لاستخدام الأدوية.
هل تشتري أو تورد هذا المركب؟
أضف مخزونك أو أنشر طلب شراء
CAS 2346620-54-8
N-benzoylcytidine
Pharmaceutical intermediate for nucleoside synthesis
5'-O-DMT-2'-O-TBDMS-Pseudouridine
Pharmaceutical intermediate for nucleoside synthesis
N-Acetyl-5'-o-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoroCytidine
Pharmaceutical intermediate for nucleoside synthesis
N-Benzoyl-2'-deoxyadenosine
Pharmaceutical intermediate for nucleoside synthesis
((3aR,4R,6R,6aR)-6-((4Z)-4-(Hydroxyimino)-2-oxo-3,4-dihydropyrimidin1(2H)-yl)-2,2-dimethyltetrahydro-2H-furo(3,4-d)(1,3)dioxol-4-yl)methyl2methylpropanoate
pharmaceutical intermediate
5-Amino-1,3,4-thiadiazole-2-thiol
Impurity in acetazolamide preparation
O-Methyl (S)-Noradrenaline
pharmaceutical intermediate for norepinephrine derivatives
1-(2,3-DICHLORO-4-HYDROXYPHENYL)BUTAN-1-ONE
Pharmaceutical intermediate
[(3aR,4R,6R,6aR)-2,2-dimethyl-4-[2-oxo-4-(1,2,4-triazol-1-yl)pyrimidin-1-yl]-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl 2-methylpropanoate
KHRVXGYHTALJEX-NMFUWQPSSA-N
CC(C)C(=O)OC[C@@H]1[C@@H]2[C@H]([C@@H](O1)N3C=CC(=NC3=O)N4C=NC=N4)OC(O2)(C)C
—